Survey on COVID-19 impact in patients with primary immune deficiency
Worldwide COVID-19 in Children and Adult Patients With Primary ImmunoDeficiencies (PID) Survey
This study is trying to learn how COVID-19 has affected people with primary immune deficiencies to better understand their experiences and outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 0 Years and up |
| Sex | All |
| Sponsor | Imagine Institute Academic / other |
| Locations | 1 site (Paris) |
| Trial ID | NCT04459689 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather data on the effects of COVID-19 on individuals diagnosed with primary immune deficiencies (PID). It follows an initial phase that assessed the number of affected PID patients and the impact of SARS-CoV-2 on this vulnerable population. The survey is conducted through a secure online platform, ensuring compliance with GDPR regulations, and is approved by the relevant ethics committee. The goal is to better understand the outcomes and consequences of COVID-19 in patients with PID.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with a primary immune deficiency who have experienced COVID-19.
Not a fit: Patients with secondary immune deficiencies or other coronavirus infections may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide critical insights into the risks and management of COVID-19 in patients with primary immune deficiencies.
How similar studies have performed: While there have been studies on COVID-19 impacts in various populations, this specific focus on primary immune deficiency is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with a Primary Immune Deficiency * COVID-19 (proven or probable) Exclusion Criteria: * Secondary Immune Deficiency * Other Coronovirus infection
Where this trial is running
Paris
- Imagine Institute — Paris, France (Recruiting)
Study contacts
- Study coordinator: Nizar MAHLAOUI, MD, MPH, PhD
- Email: nizar.mahlaoui@aphp.fr
- Phone: +33144494622
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.